Originally published In Press as doi:10.1074/jbc.M202513200 on April 10, 2002
J. Biol. Chem., Vol. 277, Issue 25, 22421-22425, June 21, 2002
Stopped-flow Kinetic Analysis of the Reaction Catalyzed by
the Full-length Yeast Cystathionine
-Synthase*
Shinichi
Taoka and
Ruma
Banerjee
From the Biochemistry Department, University of Nebraska, Lincoln,
Nebraska 68588-0664
Received for publication, March 14, 2002
 |
ABSTRACT |
Cystathionine
-synthase found in yeast
catalyzes a pyridoxal phosphate-dependent
condensation of homocysteine and serine to form cystathionine. Unlike
the homologous mammalian enzymes, yeast cystathionine
-synthase
lacks a second cofactor, heme, which facilitates detailed kinetic
studies of the enzyme because the different pyridoxal phosphate-bound
intermediates can be followed by their characteristic absorption
spectra. We conducted a rapid reaction kinetic analysis of the
full-length yeast enzyme in the forward and reverse directions. In the
forward direction, we observed formation of the external aldimine of
serine (14 mM
1 s
1) and
the aminoacrylate intermediate (15 s
1). Homocysteine
binds to the aminoacrylate with a bimolecular rate constant of 35 mM
1 s
1 and rapidly converts to
cystathionine (180 s
1), leading to the accumulation of a
420 nm absorbing species, which has been assigned as the external
aldimine of cystathionine. Release of cystathionine is slow
(k = 2.3 s
1), which is similar to
kcat (1.7 s
1) at 15 °C,
consistent with this being a rate-determining step. In the reverse
direction, cystathionine binds to the enzyme with a bimolecular rate
constant of 1.5 mM
1 s
1 and is
rapidly converted to the aminoacrylate without accumulation of the
external aldimine. The kinetic behavior of the full-length enzyme shows
notable differences from that reported for a truncated form of the
enzyme lacking the C-terminal third of the protein (Jhee, K. H.,
Niks, D., McPhie, P., Dunn, M. F., and Miles, E. W. (2001)
Biochemistry 40, 10873-10880).
 |
INTRODUCTION |
In mammals, cystathionine
-synthase catalyzes the first step in
the "reverse" trans-sulfuration pathway that converts the essential
amino acid, methionine, to cysteine. In addition, it plays a key role
in regulating the intracellular concentrations of homocysteine, a
sulfur-containing amino acid that is correlated with a number of
diseases at elevated levels including neural tube defects,
cardiovascular diseases, and Alzheimer's disease (1-3). Mutations in
cystathionine
-synthase are the single most common cause of severe
hyperhomocysteinemia, and approximately half of the patients are
pyridoxine-responsive, i.e. they benefit from treatment with
high doses of the vitamin B6 precursor, pyridoxine (4).
Thus far, >90 different mutations have been described in the
cystathionine
-synthase gene in homocystinuric patients, with the
vast majority being missense and private mutations (5). Cystathionine
-synthase catalyzes the condensation of serine and homocysteine to
give cystathionine in a pyridoxal phosphate (PLP)1-dependent
reaction. Cystathionine is subsequently cleaved in the
trans-sulfuration pathway by another PLP-dependent enzyme,
-cystathionase, to give cysteine and
-ketoglutarate.
Cystathionine
-synthases from Trypanosoma cruzi, Saccharomyces
cerevisiae, and humans have highly homologous sequences. All are
predicted to belong to the
or Fold II family of
PLP-dependent enzymes (6, 7). This similarity is borne out
in the three-dimensional structure of the catalytic PLP-containing core
of the enzyme, which has been reported recently (8), and resembles
those of related PLP enzymes, viz. O-acetyl
serine sulfhydrylase (9) and threonine deaminase (10). A major
difference between the lower and higher eukaryotic cystathionine
-synthases that have been characterized so far is the presence of a
second cofactor, iron protoporphyrin IX (11), in the mammalian enzymes,
which has unusual spectroscopic properties (12-15). The binding site for the heme is located in a 66-amino acid-long N-terminal extension that is missing in the yeast enzyme (8, 16). The heme is distant from
the PLP, which is bound in the active site, and appears to play a
regulatory role. In addition, S-adenosylmethionine
serves as an allosteric effector of the mammalian but not the yeast
enzyme, and binds to the C-terminal region of the protein (17).
The full-length yeast and human enzymes appear to exist in multiple
oligomeric states as suggested by their broad elution profiles on gel
filtration columns and their range from tetramer to octamer (13, 18). A
hypersensitive proteolysis site results in the facile generation of a
truncated species, the catalytic core, which exists as a dimer (18,
19). The dimeric human and yeast forms display high levels of enzyme
activity and differences in their steady-state kinetic properties
versus the corresponding full-length enzymes. A
pre-steady-state kinetic characterization of the truncated form of the
yeast enzyme has been reported recently (20). The truncated human
enzyme retains its heme but loses sensitivity to regulation by
S-adenosylmethionine (19). Although the reaction catalyzed
by cystathionine
-synthase superficially resembles those catalyzed
by other PLP-dependent
-replacement enzymes such as
tryptophan synthase and O-acetyl serine sulfhydrylase, mechanistic and kinetic studies with potential suicide inactivators on
the rat enzyme, reported by Borcsok and Abeles (21), have suggested some notable differences (21).
In general, rapid reaction kinetic analyses of
PLP-dependent enzymes provide a rich source of information
on the identity of catalytic intermediates. However, the presence of
heme in the human enzyme dwarfs the spectroscopic signatures associated
with the PLP species and renders these measurements difficult. As a first step toward identifying the intermediates in the reaction catalyzed by cystathionine
-synthase, we used rapid reaction kinetics to characterize the full-length tetrameric form of the yeast
enzyme as both a model and a guide for future studies on the human
enzyme. We report a number of significant differences in the kinetics
of the full-length yeast enzyme compared with that of the truncated
form, engineered by deletion of C-terminal residues 354-507, which was
reported recently (20).
 |
EXPERIMENTAL PROCEDURES |
Materials--
Serine, D,L-homocysteine,
and L-cystathionine were purchased from Sigma. The
concentration of homocysteine was determined spectrophotometrically
using Ellman's reagent (22).
Purification and Steady-state Kinetic Analysis of Yeast
Cystathionine
-Synthase--
Full-length yeast cystathionine
-synthase was purified as described previously using a recombinant
expression vector, pSEC (23), provided by Dr. Edith Miles
(National Institutes of Health, Bethesda, MD). The activity of the
enzyme and the steady-state kinetic parameters were measured in the
radioactive assay as described previously (13). To determine the
effects of preincubation with either serine or homocysteine, the enzyme
was mixed with the first substrate for 5 min at 37 °C before being
exposed to the second substrate, and the reaction was allowed to
proceed for 30 min. For determination of substrate
Km values, the concentration of the
second substrate was fixed at 30 mM, whereas that of the
first was varied.
Rapid Reaction Kinetics--
Stopped flow experiments were
performed on an Applied Photophysics spectrophotometer (SX.MV18)
equipped with a photodiode array detector. The temperature of the
mixing chamber was maintained at 15 ± 1 °C and was controlled
by a circulating water bath. A solution containing yeast cystathionine
-synthase (18 µM) in 0.2 mM Tris buffer,
pH 8, was mixed with varying concentrations of substrate in the same
buffer, as indicated in the figure legends. When the reaction of
preformed aminoacrylate with homocysteine was monitored, 18 µM enzyme was premixed with 30 mM serine in 0.2 M Tris, pH 8.0, and mixed rapidly with varying
concentrations of homocysteine. Because of the limited solubility of
cystathionine, a stock solution (0.5 M) was made in 0.8 N NaOH, and aliquots of this solution were diluted to give
the desired concentration in 0.2 M Tris buffer, pH 8. The
concentrations of enzyme and substrate refer to those before mixing;
both solutions were diluted 2-fold after mixing. The reactions were
followed with a photo-diode array detector.
Typically, time-dependent spectra were analyzed by the
single value decomposition algorithm which is an integral feature of Pro-K program (Global Analysis for Spectra, Kinetic Data, version 4.20)
supplied by Applied Photophysics. A set of output matrices comprising
ordered sets of basis spectra and time-dependent amplitudes was obtained together with corresponding weighting factors known as
singular values. The number of significant singular values is a
model-free indication of the number of independent components present
in the original data set. A kinetic model was built based on the number
of independent spectra predicted by this method. The reported rate
constants are the average of at least two different rapid mixing
experiments. The spectra (recorded between 300 and 600 nm and between
1.3 and 500 ms), each containing 57,200 data points, were fit to
Equation 1,
|
(Eq. 1)
|
where C is the amplitude, k is the rate
constant, and OD, the optical density, is the sum of the absorbance of
the individual species (
i) contributing to a given
spectrum, each of which is described by Equation 2.
|
(Eq. 2)
|
 |
RESULTS |
Steady-state Kinetic Analysis of Full Length Yeast Cystathionine
-Synthase--
The kinetic parameters, Vmax
and Km, for the yeast cystathionine
-synthase
under steady-state conditions are presented in Table
I and are comparable with those reported
previously (18). Unlike the human enzyme, the activity of the
yeast enzyme is unaffected by whether it is preincubated with serine or
homocysteine. The yeast cystathionine
-synthase displays a
bell-shaped dependence on pH with an optimum at 8.1 and inflection
points corresponding to pKa values of 7.7 ± 0.1 and 8.8 ± 0.1, respectively (data not shown).
View this table:
[in this window]
[in a new window]
|
Table I
Summary of steady-state kinetic parameters for full-length yeast
cystathionine -synthase determined under serine or homocysteine
preincubation conditions
|
|
Reaction of Cystathionine
-Synthase with Serine--
Absorbance
changes resulting from rapid mixing of cystathionine
-synthase with
serine are shown in Fig. 1A.
Global analysis of the spectrum (Fig. 1B) indicated the
presence of three species assigned as the internal aldimine
(
max = 412 nm), the external aldimine
(
max = 416 nm), and the aminoacrylate
(
max = 460 nm). There was no evidence for a gem-diamine
(with a
max = 320 nm) at high serine concentrations or
for a tautomeric form of the aminoacrylate (with a
max
320 nm) at low serine concentration as reported for the truncated
yeast cystathionine
-synthase (20). Formation of the external
aldimine was linearly dependent on the concentration of serine (Fig.
1C) and yielded a bimolecular rate constant of 14 mM
1 s
1 and a
Kd for serine of 1.5 ± 0.3 mM.
Formation of the aminoacrylate showed saturation dependence on the
concentration of serine and a maximal rate constant of 15 ± 0.4 s
1. For comparison, the kcat for
yeast cystathionine
-synthase at 15 °C is 1.7 s
1
calculated per mole of monomer of 56 kDa molecular mass.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
Spectral changes resulting from the addition
of serine to the cystathionine -synthase.
Enzyme (18 µM) was mixed with varying concentrations of
serine in 0.2 M Tris, pH 8.0. A, absorption
changes seen between 1.3 and 500 ms after mixing 1.5 mM
serine with enzyme are shown. The resting enzyme has an absorption
maximum at 412 nm (internal aldimine) that is converted to a species
with an absorption maximum at 460 nm, assigned as the aminoacrylate.
B, global fitting of the time-dependent spectra
in A reveals the presence of three species with absorption
maxima at 412 (a), 416 (b), and 460 nm
(c), respectively. C, dependence of the apparent
rates of formation of the external aldimine ( ) and the aminoacrylate
( ) on the concentration of serine.
|
|
Reaction of E·Aminoacrylate with Homocysteine--
Kinetics of
the second half reaction, i.e. addition of homocysteine to the
aminoacrylate intermediate to form cystathionine, was followed by
preincubating 18 µM enzyme with 30 mM serine
to preform the aminoacrylate, which was then rapidly mixed with varying concentrations (0-60 µM) of
D,L-homocysteine. At low concentrations of
homocysteine, a decrease in the absorbance of the aminoacrylate intermediate is observed at 460 nm with a concomitant blue shift in the
spectrum (Fig. 2A). In
contrast, the disappearance of the preformed aminoacrylate with the
truncated yeast cystathionine
-synthase was reported to be too fast
to measure even at low homocysteine concentration (20). However, at
high concentrations of homocysteine, the decay of the aminoacrylate is
completely missed (Fig. 2B), indicating that the reaction is
rapid and largely over within the dead time of the instrument (2.2 ms).
Instead, a rapid decrease at 420 nm, with a
kobsd of 180 ± 5 s
1, is
observed followed by a slow increase in absorption at the same
wavelength with a rate constant of 0.7 s
1 (Fig.
2C). The species at 420 nm is tentatively assigned as the external aldimine of cystathionine, and its rate of formation is
identical to the rate of disappearance of the 460 nm aminoacrylate at
low concentrations of homocysteine (Fig. 2D). The nature of the change leading to an increase in the extinction coefficient of the
420 nm-absorbing species at a rate of 0.7 s
1 is not
understood, and it is too slow to be catalytically relevant.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 2.
Spectral changes resulting from the addition
of homocysteine to preformed aminoacrylate. Cystathionine
-synthase (18 µM) was premixed with 30 mM
serine and varying concentrations of homocysteine in 0.2 M
Tris, pH 8.0. A, spectral changes observed between 1.3 and
500 ms after the addition of 0.15 mM
D,L-homocysteine. B, spectral
changes observed between 1.3 and 500 ms after the addition of 60 mM D,L-homocysteine. C,
kinetics of absorption changes at 420 nm in the presence of 1 mM D,L-homocysteine. A rapid
decline in the absorption occurs at a rate of 180 s 1
followed by a slow increase at a rate of 0.7 s 1.
D, dependence of the apparent rate of disappearance of the
aminoacrylate ( max = 460 nm) ( ) and the formation of
the 420 nm-absorbing external aldimine of cystathionine ( ) on the
concentration of homocysteine (after mixing). At high concentrations of
homocysteine, the disappearance of the 460 nm species is too fast to be
measured.
|
|
The dependence of the rate of disappearance of the aminoacrylate on the
concentration of homocysteine yields a bimolecular rate constant of
35 ± 0.6 mM
1 s
1 and a
Kd for homocysteine of 0.68 ± 0.03 mM (Fig. 2D).
Reaction of Enzyme with Cystathionine--
Rapid mixing of enzyme
with cystathionine resulted in conversion of the external aldimine
(
max = 412 nm) to the aminoacrylate with a
max of 460 nm (Fig.
3A). A clean isosbestic point
is observed at 426 nm, indicating that an intermediate such as the
external aldimine of cystathionine does not accumulate to detectable
levels. Hence, the complexes between enzyme and cystathionine formed in the forward and reverse directions appear to be different. When equimolar serine and homocysteine are mixed with enzyme, the spectrum of the enzyme (
max = 420 nm) is consistent with the
presence of the external aldimine of cystathionine (Fig.
2B), for which release is slow and presumably limits the
overall reaction. In contrast, when the enzyme is mixed with
cystathionine, the external aldimine is not detected, and the
aminoacrylate form accumulates (Fig. 3A). The dependence of
the rate of aminoacrylate formation on the concentration of
cystathionine yields a bimolecular rate constant of 1.5 ± 0.1 mM
1 s
1 and a
Kd for cystathionine of 1.6 ± 0.3 mM (Fig. 3B). The limited solubility of
cystathionine precluded measurements at concentrations above 15 mM.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 3.
Spectral changes resulting from the addition
of cystathionine to cystathionine
-synthase. Enzyme (18 µM) in 0.2 M Tris, pH 8.0, was mixed with varying concentrations of
L-cystathionine in the same buffer. A, spectral
changes observed between 2.5 and 1000 ms after addition of 30 mM cystathionine. Conversion of the 412 nm resting enzyme
spectrum to a 460-nm aminoacrylate species is observed with an
isosbestic point at 426 nm. B, dependence of the apparent
rate for formation of the aminoacrylate species on the concentration of
cystathionine.
|
|
 |
DISCUSSION |
Differences in the spectroscopic signatures associated with the
bound intermediates in PLP-dependent enzymes provide a
convenient means for analyzing the kinetics of their formation and
decay. Steady-state kinetic analysis of the yeast cystathionine
-synthase indicates that it catalyzes a ping-pong reaction in which
serine binds to generate an enzyme-bound aminoacrylate intermediate
that reacts with homocysteine to give cystathionine (18). In this study, we report a pre-steady-state kinetic analysis of the reaction catalyzed by the full-length yeast cystathionine
-synthase and note
several differences between the behavior of this enzyme
versus that of a truncated form that was reported earlier
(20). The C-terminal amino acids from positions 354 to 507 were deleted in the truncated form, which resulted in a change in the
oligomerization state from octameric to dimeric and an increase in the
catalytic efficiency of the enzyme (18). Similar changes accompany
deletion of the C-terminal 143 amino acids in the human enzyme
(19).
The binary reaction of serine with enzyme to form the aminoacrylate
proceeds via a detectable intermediate, the external aldimine (Scheme
I). The observed rates of formation of
the external aldimine and the aminoacrylate show a linear and
hyperbolic dependence respectively on serine concentration (Fig.
1C). The Kd for serine obtained from this
analysis is 1.5 ± 0.3 mM, which is slightly lower
than that reported for the truncated enzyme (4.6 ± 0.8 mM). The rate of aminoacrylate formation is 14 ± 0.5 s
1, which is 8-fold greater than
kcat but slower than the rate of aminoacrylate
formation in the reverse direction from cystathionine (Scheme
II). Formation of the aminoacrylate in
the forward direction involves elimination of a poor leaving
group (OH
) from the substrate, and would require
enzyme assisted protonation (Scheme I). In contrast, formation of the
aminoacrylate from cystathionine in the reverse reaction involves
elimination of a better leaving group (thiolate) and may explain the
difference in the rates (Scheme II).

View larger version (20K):
[in this window]
[in a new window]
|
Scheme I.
Intermediates in the reaction catalyzed by
cystathionine -synthase and their absorption
maxima as determined in this study. The two gem-diamine
intermediates (GD-I and GD-II), shown in
square brackets, were not observed in the pre-steady-state
kinetic analysis of the full-length yeast enzyme. AA and
Cyst denote aminoacrylate and cystathionine, respectively.
|
|

View larger version (17K):
[in this window]
[in a new window]
|
Scheme II.
Minimal kinetic scheme for reaction
catalyzed by yeast cystathionine -synthase in
the forward and reverse directions. The values shown in
parentheses in A are taken from B,
where the reaction was followed in the reverse direction.
|
|
In the truncated enzyme, the external aldimine of serine was not
observed, and the kobsd reported for
aminoacrylate formation (177 s
1) is comparable with the
rate we observe for the disappearance of the internal aldimine at high
serine concentration (~200 s
1, Fig. 1C). The
observation of the external aldimine intermediate with the full-length
enzyme allows deconvolution of the kobsd into
bi- and unimolecular rate constants as shown in Fig. 1C.
The second-half reaction, i.e. conversion of the
aminoacrylate to cystathionine, can be monitored by mixing preformed
aminoacrylate with homocysteine. The disappearance of the aminoacrylate
can be monitored at low but not high concentrations of homocysteine, where the reaction is over in the dead time of the instrument. The
product of this reaction has an absorption maximum at 420 nm and is
assigned as the external aldimine of cystathionine. The rate constant
for the decrease in absorbance at 420 nm (180 ± 5 s
1) parallels the rate constant for the disappearance of
the aminoacrylate at low homocysteine concentrations where the rate can
be measured (Fig. 2D). The initial decrease (rather than
increase) in absorbance at this wavelength may be due to the difference
in the extinction coefficients of the aminoacrylate and the external
aldimine at 420 nm. This is followed by a slow (0.7 s
1)
and a low amplitude increase in absorption at the same wavelength, the
basis of which is not known. This increase could result from a
conformational change in the protein that leads to a change in the
extinction coefficient of the external aldimine.
The reaction of cystathionine and enzyme to form an
aminoacrylate species shows monophasic kinetics, and formation
of an external aldimine intermediate is not observed (Fig.
3A). The observed rate constant for aminoacrylate formation
in the reverse direction shows a hyperbolic dependence on cystathionine
concentration and yields a Kd of 1.6 ± 0.3 mM, which is lower than the Kd reported
for the truncated enzyme (7.45 ± 0.8 mM) (20). As
noted previously, this enzyme exhibits substrate inhibition with
homocysteine, and the reaction of cystathionine with enzyme is not a
simple reversal of the forward reaction, i.e. the reaction of preformed aminoacrylate with homocysteine (20).
The accumulation of the 420 nm species in the forward direction
assigned as the external aldimine of cystathionine (Fig. 2B) indicates that product release is rate-limiting, a conclusion that was
also reached with the truncated enzyme (20). Based on the kinetics of
the reverse reaction, the rate of cystathionine release from the enzyme
is 2.3 s
1, which is similar to
kcat (1.7 s
1) and is consistent
with this being a rate-determining step (Scheme II).
In summary, notable differences are observed in the pre-steady-state
kinetic analysis of intermediates in the reactions catalyzed by
full-length and truncated yeast cystathionine
-synthase. A gem-diamine intermediate is seen in the presence of serine with the
truncated but not full-length enzyme, whereas the external aldimine of
serine is observed with full-length but not truncated enzyme.
Similarly, a 320 nm absorbance assigned as the gem-diamine of
cystathionine is observed when the aminoacrylate is mixed with homocysteine in the truncated but not the full-length enzyme. Quinonoid
intermediates are not seen with either enzyme form, which is similar to
the reaction catalyzed by the closely related PLP-dependent
enzyme, O-acetyl serine sulfhydralase (24). This has been
rationalized by Cook and co-workers (9) to result from the
mismatch in the pKa values of the N1 of PLP and
Ser-272, making protonation of N1 unlikely and thereby
disfavoring quinonoid formation. A homologous serine is conserved in
both yeast and human cystathionine
-synthase (25). The studies with the full-length yeast enzyme should be useful in elucidating the kinetic mechanism of the human enzyme.
 |
FOOTNOTES |
*
This work was supported by Grant HL58984 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
An Established Investigator of the American Heart Association. To
whom correspondence should be addressed. Tel.: 402-472-2941; E-mail:
rbanerjee1@unl.edu.
Published, JBC Papers in Press, April 10, 2002, DOI 10.1074/jbc.M202513200
 |
ABBREVIATIONS |
The abbreviation used is:
PLP, pyridoxal
phosphate.
 |
REFERENCES |
| 1.
|
Refsum, H.,
Ueland, P. M.,
Nygard, O.,
and Vollset, S. E.
(1998)
Annu. Rev. Med.
49,
31-62[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Mills, J. L.,
McPartlin, J. M.,
Kirke, P. N.,
Lee, Y. J.,
Conle, M. R.,
and Weir, D. G.
(1995)
Lancet
345,
149-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Clarke, R.,
Smith, A. D.,
Jobst, K. A.,
Refsum, H.,
Sutton, L.,
and Ueland, P. M.
(1998)
Arch. Neurol.
55,
1449-1455[Abstract/Free Full Text]
|
| 4.
|
Mudd, S. H.,
Skovby, F.,
Levy, H. L.,
Pettigrew, K. D.,
Wilcken, B.,
Pyeritz, R. E.,
Andria, G.,
Boers, G. H.,
Bromberg, I. L.,
Cerone, R.,
et al..
(1985)
Am. J. Hum. Genet.
37,
1-31[Medline]
[Order article via Infotrieve]
|
| 5.
|
Kraus, J. P.,
Janosik, M.,
Kozich, V.,
Mandell, R.,
Shih, V.,
Sperandeo, M. P.,
Sebastio, G.,
de Franchis, R.,
Andria, G.,
Kluijtmans, L. A.,
Blom, H.,
Boers, G. H.,
Gordon, R. B.,
Kamoun, P.,
Tsai, M. Y.,
Kruger, W. D.,
Koch, H. G.,
Ohura, T.,
and Gaustadnes, M.
(1999)
Hum. Mutat.
13,
362-375[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Alexander, F. W.,
Sandmeier, E.,
Mehta, P. K.,
and Christen, P.
(1994)
Eur. J. Biochem.
219,
953-960[Medline]
[Order article via Infotrieve]
|
| 7.
|
Grishin, N. V.,
Phillips, M. A.,
and Goldsmith, E. J.
(1995)
Protein Sci.
4,
1291-1304[Abstract]
|
| 8.
|
Meier, M.,
Janosik, M.,
Kery, V.,
Kraus, J. P.,
and Burkhard, P.
(2001)
EMBO J.
20,
3910-3916[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Burkhard, P.,
Rao, G. S.,
Hohenester, E.,
Schnackerz, K. D.,
Cook, P. F.,
and Jansonius, J. N.
(1998)
J. Mol. Biol.
283,
121-133[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Gallagher, D. T.,
Gilliland, G. L.,
Xiao, G.,
Zondlo, J.,
Fisher, K. E.,
Chinchilla, D.,
and Eisenstein, E.
(1998)
Structure
6,
465-475[Medline]
[Order article via Infotrieve]
|
| 11.
|
Kery, V.,
Bukovska, G.,
and Kraus, J. P.
(1994)
J. Biol. Chem.
269,
25283-25288[Abstract/Free Full Text]
|
| 12.
|
Taoka, S.,
Green, E. L.,
Loehr, T. M.,
and Banerjee, R.
(2001)
J. Inorg. Biochem.
87,
253-259[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Taoka, S.,
Ohja, S.,
Shan, X.,
Kruger, W. D.,
and Banerjee, R.
(1998)
J. Biol. Chem.
273,
25179-25184[Abstract/Free Full Text]
|
| 14.
|
Taoka, S.,
and Banerjee, R.
(2001)
J. Inorg. Biochem.
87,
245-251[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Ojha, S.,
Hwang, J.,
Kabil, O.,
Penner-Hahn, J. E.,
and Banerjee, R.
(2000)
Biochemistry
39,
10542-10547[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Ojha, S., Wu, J.,
LoBrutto, R.,
and Banerjee, R.
(2002)
Biochemistry
41,
4649-4654[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Finkelstein, J. D.,
Kyle, W. E.,
Martin, J. J.,
and Pick, A.-M.
(1975)
Biochem. Biophys. Res. Commun.
66,
81-87[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Jhee, K. H.,
McPhie, P.,
and Miles, E. W.
(2000)
Biochemistry
39,
10548-10556[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Taoka, S.,
Widjaja, L.,
and Banerjee, R.
(1999)
Biochemistry
38,
13155-13161[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Jhee, K. H.,
Niks, D.,
McPhie, P.,
Dunn, M. F.,
and Miles, E. W.
(2001)
Biochemistry
40,
10873-10880[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Borcsok, E.,
and Abeles, R. H.
(1982)
Arch. Biochem. Biophys.
213,
695-707[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Ellman, G. L.
(1959)
Arch. Biochem. Biophys.
82,
70-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Jhee, K. H.,
McPhie, P.,
and Miles, E. W.
(2000)
J. Biol. Chem.
275,
11541-11544[Abstract/Free Full Text]
|
| 24.
|
Tai, C.-H.,
and Cook, P. F.
(2001)
Acc. Chem. Res.
34,
49-59[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Kabil, Ö.,
Taoka, S.,
LoBrutto, R.,
Shoemaker, R.,
and Banerjee, R.
(2001)
J. Biol. Chem.
276,
19350-19355[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. W. Miles and J. P. Kraus
Cystathionine {beta}-Synthase: Structure, Function, Regulation, and Location of Homocystinuria-causing Mutations
J. Biol. Chem.,
July 16, 2004;
279(29):
29871 - 29874.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Oliveriusova, V. Kery, K. N. Maclean, and J. P. Kraus
Deletion Mutagenesis of Human Cystathionine beta -Synthase. IMPACT ON ACTIVITY, OLIGOMERIC STATUS, AND S-ADENOSYLMETHIONINE REGULATION
J. Biol. Chem.,
December 6, 2002;
277(50):
48386 - 48394.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.